Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Settings
GTXI [NASD]
GTX Inc.
Index- P/E- EPS (ttm)-0.55 Insider Own40.50% Shs Outstand76.04M Perf Week-1.53%
Market Cap73.38M Forward P/E- EPS next Y-0.42 Insider Trans18.49% Shs Float22.86M Perf Month-22.80%
Income-36.70M PEG- EPS next Q-0.10 Inst Own6.00% Short Float12.90% Perf Quarter-41.16%
Sales- P/S- EPS this Y-3.10% Inst Trans-30.50% Short Ratio6.60 Perf Half Y-45.79%
Book/sh0.20 P/B4.82 EPS next Y12.50% ROA-168.30% Target Price1.00 Perf Year-29.56%
Cash/sh0.23 P/C4.24 EPS next 5Y0.00% ROE-215.30% 52W Range0.81 - 2.36 Perf YTD-41.52%
Dividend- P/FCF- EPS past 5Y14.10% ROI- 52W High-59.11% Beta1.28
Dividend %- Quick Ratio5.00 Sales past 5Y- Gross Margin- 52W Low19.14% ATR0.06
Employees27 Current Ratio5.00 Sales Q/Q- Oper. Margin- RSI (14)31.54 Volatility4.33% 7.02%
OptionableYes Debt/Eq0.00 EPS Q/Q25.00% Profit Margin- Rel Volume0.19 Prev Close0.97
ShortableYes LT Debt/Eq0.00 EarningsAug 05 BMO Payout- Avg Volume447.03K Price0.96
Recom3.00 SMA20-8.05% SMA50-21.04% SMA200-36.11% Volume85,546 Change-0.52%
05-Apr-13Initiated Stifel Buy $7
14-Oct-11Initiated Rodman & Renshaw Mkt Outperform $7
20-Jul-11Initiated Wedbush Outperform $13
27-Oct-10Upgrade Rodman & Renshaw Mkt Underperform → Mkt Perform
26-May-10Reiterated Rodman & Renshaw Mkt Underperform $1.75 → $1.25
17-Mar-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $1.75
26-Jan-09Reiterated Leerink Swann Mkt Perform $18 → $10
22-Jan-09Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
23-May-08Downgrade Cowen & Co Outperform → Neutral
25-Mar-08Initiated Rodman & Renshaw Mkt Outperform $22
07-Nov-07Reiterated Lazard Capital Buy $28 → $31
06-Nov-07Reiterated Broadpoint Capital Buy $26 → $29
11-Oct-07Initiated Wachovia Outperform
13-Sep-07Initiated First Albany Buy $26
10-May-07Initiated Citigroup Hold $24
30-Apr-07Downgrade Leerink Swann Outperform → Mkt Perform
24-Apr-07Reiterated HSBC Securities Overweight $25 → $29
18-Apr-07Reiterated Lazard Capital Buy $25 → $28
18-Apr-07Reiterated AG Edwards Buy $23 → $28
26-Feb-07Reiterated Lazard Capital Buy $21 → $25
15-Aug-14 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials
07-Aug-14 07:30AM  GTx Announces Webcast of Corporate Presentation at the 2014 Wedbush Pacgrow Life Sciences Management Access Conference Business Wire -11.76%
05-Aug-14 07:30AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q2 2014 GTx, Inc. Earnings Release - Before Market Open CCBN
07:00AM  GTx Provides Corporate Update and Reports Second Quarter 2014 Financial Results Business Wire
22-Jul-14 07:30AM  GTx, Inc. to Report Second Quarter 2014 Financial Results on August 5, 2014 Business Wire
02-Jul-14 08:18AM  4 Biotech Stocks Under $10 to Watch for Breakout Trades at TheStreet
12-Jun-14 06:00AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
06:00AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
02-Jun-14 02:54PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -14.46%
02:54PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
11:03AM  GTx reports results from Phase 2 study of enobosarm theflyonthewall.com
11:03AM  GTx reports results from Phase 2 study of enobosarm
11:01AM  GTx Reports Positive Clinical Data from Open Label Phase 2 Study of Enobosarm in Patients with Androgen and Estrogen Receptor Positive Metastatic Breast Cancer Business Wire
11:01AM  GTx Reports Positive Clinical Data from Open Label Phase 2 Study of Enobosarm in Patients with Androgen and Estrogen Receptor Positive Metastatic Breast Cancer
29-May-14 06:12AM  GTX Inc. (GTXI) Soars: Stock Up 9.7% Zacks
06:12AM  GTX Inc. (GTXI) Soars: Stock Up 9.7%
22-May-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2014 Global Healthcare Conference Business Wire
07:30AM  GTx Announces Webcast of Corporate Presentation at Jefferies 2014 Global Healthcare Conference
19-May-14 07:00AM  GTx to Present Clinical Data on Enobosarm in Breast Cancer and NSCLC at ASCO 2014 Annual Meeting Business Wire
07:00AM  GTx to Present Clinical Data on Enobosarm in Breast Cancer and NSCLC at ASCO 2014 Annual Meeting
16-May-14 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials
01:04PM  GTX INC /DE/ Financials
12-May-14 05:04PM  GTx files to sell $150M of common stock, warrants at theflyonthewall.com
05:04PM  GTx files to sell $150M of common stock, warrants
07:32AM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report EDGAR Online
07:32AM  GTX INC /DE/ Files SEC form 10-Q, Quarterly Report
09-May-14 04:51PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; EDGAR Online +5.34%
08-May-14 11:08AM  GTx says current POWER trials data insufficient to support filing NDA at theflyonthewall.com -11.49%
07:32AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:07AM  Q1 2014 GTx, Inc. Earnings Release - Before Market Open CCBN
07:03AM  GTx reports Q1 EPS (14c), consensus (12c) at theflyonthewall.com
07:00AM  GTx Provides Corporate Update and Reports First Quarter 2014 Financial Results Business Wire
30-Apr-14 06:39AM  GTX Inc. (GTXI) Jumps: Stock Up 14.4% Zacks
29-Apr-14 08:40AM  Pitt Hyde & Mason Hawkins Buy >50% Stake In GTx Ahead Of Phase II Results at Seeking Alpha +14.39%
24-Apr-14 07:30AM  GTx, Inc. To Report First Quarter 2014 Financial Results On May 8, 2014 Business Wire
15-Apr-14 08:56AM  GTx Chief Scientific Officer James Dalton resigns at theflyonthewall.com
08:46AM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04-Apr-14 04:37PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
07:01AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
06:25AM  GTx Announces Departure of CEO Business Wire
25-Mar-14 01:23PM  NVIDIA announces Titan Z: a $3,000 graphics computing powerhouse at Engadget
19-Mar-14 07:47AM  Strength Seen in GTX (GTXI): Stock Moves 8.8% Higher Zacks
18-Mar-14 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials +8.79%
12-Mar-14 04:32PM  GTX INC /DE/ Files SEC form 10-K, Annual Report EDGAR Online
06-Mar-14 05:14PM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
05:05PM  GTx, Inc. Announces Closing of Private Placement Business Wire
05:05PM  GTx, Inc. Announces Closing of Private Placement
05-Mar-14 08:50AM  Narrower-than-Expected Q4 Loss at GTx Zacks
08:50AM  Narrower-than-Expected Q4 Loss at GTx
07:30AM  GTx Announces Webcast of Corporate Presentation at 26TH Annual ROTH Conference Business Wire
07:30AM  GTx Announces Webcast of Corporate Presentation at 26TH Annual ROTH Conference
04-Mar-14 04:17PM  GTX INC /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, EDGAR Online +5.95%
03:18PM  GTx's CEO Discusses Q4 2013 Results - Earnings Call Transcript at Seeking Alpha
03:18PM  GTx's CEO Discusses Q4 2013 Results - Earnings Call Transcript
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
08:00AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
07:34AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q4 2013 GTx, Inc. Earnings Release - Before Market Open CCBN
07:00AM  GTx Provides Corporate Update and Reports 2013 Financial Results Business Wire
07:00AM  GTx Provides Corporate Update and Reports 2013 Financial Results
06:30AM  GTx, Inc. Announces Pricing of Private Placement Business Wire
26-Feb-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Cowen and Company 34th Annual Health Care Conference Business Wire
20-Feb-14 09:08PM  Nvidia Is About To Steal The Cryptocurrency Mining Crown From AMD at Forbes
19-Feb-14 10:49AM  NVIDIA Titan Black cards bring much improved specs, even crazier prices at Engadget
18-Feb-14 07:30AM  GTx, Inc. To Host Fourth Quarter and Full Year 2013 Financial Results Conference Call and Webcast Business Wire
10-Feb-14 07:02AM  GTX INC /DE/ Files SEC form 8-K, Regulation FD Disclosure EDGAR Online
04-Feb-14 07:30AM  GTx Announces Webcast of Corporate Presentation at Bio CEO & Investor Conference Business Wire
29-Jan-14 08:04AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
08:04AM  GTX INC /DE/ Files SEC form 8-K, Other Events, Financial Statements and Exhibits
07:30AM  Preliminary findings from the Phase 2 clinical trial of GTx-758 in men with castration resistant prostate cancer to be presented at ASCO Genitourinary Cancer Symposium Business Wire
07:30AM  Preliminary findings from the Phase 2 clinical trial of GTx-758 in men with castration resistant prostate cancer to be presented at ASCO Genitourinary Cancer Symposium
07-Jan-14 06:50AM  GTX Inc. (GTXI) Worth Watching: Stock Rises 7.2% Zacks
06:50AM  GTX Inc. (GTXI) Worth Watching: Stock Rises 7.2%
23-Dec-13 04:17PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:17PM  GTX INC /DE/ Files SEC form 8-K, Change in Directors or Principal Officers
19-Dec-13 02:48PM  5 Stocks Under $10 Set to Soar at TheStreet
02:48PM  5 Stocks Under $10 Set to Soar
12-Dec-13 07:30AM  GTx Presents on Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer at the San Antonio Breast Cancer Symposium Business Wire
07:30AM  GTx Presents on Enobosarm as Targeted Therapy for the Treatment of Androgen Receptor-Positive Breast Cancer at the San Antonio Breast Cancer Symposium
11-Dec-13 12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC The Verge -5.84%
12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC at The Verge
12:22PM  Digital Storm's first Steam Machine will be a $1,469 gaming PC
21-Nov-13 06:37AM  Investors are betting against GTx, Inc. (GTXI), Should You? Zacks
06:37AM  Investors are betting against GTx, Inc. (GTXI), Should You?
19-Nov-13 01:04PM  GTX INC /DE/ Financials EDGAR Online Financials
01:04PM  GTX INC /DE/ Financials
12-Nov-13 12:36PM  GTx's CEO Discusses Q3 2013 Results - Earnings Call Transcript at Seeking Alpha
12:36PM  GTx's CEO Discusses Q3 2013 Results - Earnings Call Transcript
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
09:00AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today
08:55AM  GTx, Inc. Discusses Q2 2013 Results (Webcast) at Seeking Alpha
08:55AM  GTx, Inc. Discusses Q2 2013 Results (Webcast)
08:49AM  GTx, Inc. Earnings Call scheduled for 9:00 am ET today CCBN
07:07AM  Q3 2013 GTx, Inc. Earnings Release - Before Market Open CCBN
07:01AM  GTX INC /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
06:36AM  InPlay: GTX beats by $0.07; provides clinical updates on Enobosarm Briefing.com
06:30AM  GTx Provides Corporate Update and Reports Third Quarter 2013 Financial Results Business Wire
07-Nov-13 12:00PM  Nvidia Launches GTX 780 Ti -- Faster Than Titan For $300 Less at Forbes
04-Nov-13 10:46AM  We play with the Steam Machine, Valve's game console of the future at The Verge
GTx, Inc., a biopharmaceutical company, is engaged in the discovery, development, and commercialization of small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. It is involved in developing Enobosarm 3 mg, an androgen receptor modulator, which is in Phase III clinical trial for the prevention and treatment of muscle wasting in patients with non-small cell lung cancer; and Enobosarm 9 mg, which is in Phase II clinical trial for the treatment of AR positive and ER positive metastatic breast cancer in women. The company also develops Capesaris, an oral nonsteroidal estrogen receptor alpha agonist that is in Phase II clinical trial for secondary hormonal therapy in men with metastatic or nonmetastatic castration resistant prostate cancer. GTx, Inc. was founded in 1997 and is headquartered in Memphis, Tennessee.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
HANOVER MARC STEVENInterim CEO, President and COOAug 21Buy1.0010,00010,000198,138Aug 21 04:12 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 20Buy1.0010,00010,000188,138Aug 21 04:12 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 08Buy0.9510,0009,532168,138Aug 08 03:42 PM
DOGGRELL HENRY PATTONVP, Chief Legal OfficerAug 08Buy0.9710,0009,746102,913Aug 08 04:18 PM
HANOVER MARC STEVENInterim CEO, President and COOAug 07Buy0.9230,00027,606138,138Aug 07 11:19 AM
HANOVER MARC STEVENInterim CEO, President and COOAug 07Buy0.9220,00018,348158,138Aug 08 03:42 PM
Shackelford Jason TPrin Fin. & Acct. OfficerAug 07Buy0.9210,0009,17245,263Aug 07 04:32 PM
DALTON JAMES TVP, Chief Scientific OfficerJun 06Sale1.3072,88394,7480Jun 09 05:09 PM
SCHULER JACK W10% OwnerMar 21Sale1.79638,6391,143,1646,165,261Mar 21 06:31 PM
SCHULER JACK W10% OwnerMar 20Sale1.90115,492219,4356,803,900Mar 21 06:31 PM
SCHULER JACK W10% OwnerMar 19Sale1.91438,120836,8096,919,392Mar 21 06:31 PM